In critically ill sepsis patients on antibiotics, fecal microbiota transplantation was not shown to reduce 28-day mortality compared to controls or probiotics, as the difference observed was not statistically significant and the study was too small and unbalanced to draw conclusions.
See the scientific wording
In critically ill sepsis patients receiving antibiotics, fecal microbiota transplantation is associated with a non-significant trend toward lower 28-day mortality compared to controls and probiotics, with a p-value of 0.297 and no statistical evidence of clinical benefit due to small sample size and baseline imbalances.
Backed by science
Randomized trialsOne low-scoring study supports this claim, so treat this as an early signal rather than settled science.
What the research says
1 study reviewedSupporting (1)
Randomized Controlled TrialHuman2026
In very sick sepsis patients, FMT helped fix their gut bacteria better than probiotics or no treatment, which might help them survive longer — but the study was too small to prove it for sure, which matches what the claim says.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When a person is very sick with sepsis and on strong antibiotics, their gut bacteria get wiped out and harmful bugs take over. Giving them stool from a healthy donor brings back a balanced mix of good bacteria that outcompete the bad ones, stop them from multiplying, and prevent toxins from leaking into the bloodstream. This lowers the body’s overall inflammation and stress on organs.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In critically ill sepsis patients on antibiotics, fecal microbiota transplantation was not shown to reduce 28-day mortality compared to controls or probiotics, as the difference observed was not statistically significant and the study was too small and unbalanced to draw conclusions.
Mechanism
1 studyWhen a very sick patient on antibiotics gets a stool transplant, healthy bacteria from a donor take over the gut and push out harmful bugs. This stops toxins from leaking into the blood and calms down dangerous body-wide inflammation. Probiotics don't work because the antibiotics kill them before they can settle in.
When a person is very sick with sepsis and on strong antibiotics, their gut bacteria get wiped out and harmful bugs take over. Giving them stool from a healthy donor brings back a balanced mix of good bacteria that outcompete the bad ones, stop them from multiplying, and prevent toxins from leaking into the bloodstream. This lowers the body’s overall inflammation and stress on organs.
A diverse community of viable gut microbes is introduced into the intestinal lumen through direct delivery
Keystone bacterial taxa, including Bacteroides, establish stable colonization in the gut despite ongoing antibiotic exposure
Engrafted beneficial microbes outcompete opportunistic pathogens such as Enterobacteriaceae for nutrients and space, and produce metabolites that inhibit their growth
Microbial diversity and ecosystem stability are restored, enhancing colonization resistance and preventing pathogen expansion
Reduced abundance of pathogenic bacteria decreases the production and translocation of endotoxins across the intestinal barrier
Lower systemic endotoxin levels reduce activation of innate immune pathways and dampen uncontrolled inflammation
Less supported by current evidence, but not ruled out
When probiotics are given to very sick patients on strong antibiotics, the introduced bacteria cannot survive or take hold because the antibiotics kill off the helper microbes they need and change the gut environment. This lets harmful bacteria keep growing unchecked.
Limited strains of bacteria are ingested and introduced into the antibiotic-exposed gut lumen
Broad-spectrum antibiotics suppress the growth and persistence of introduced probiotic strains by eliminating commensal support species and altering metabolic conditions
Failure of probiotic engraftment permits opportunistic pathogens to expand due to absence of competitive exclusion
Gut microbial diversity remains low and functional capacity is not restored, sustaining a pro-inflammatory state
Evidence from Studies
Supporting (1)
Community contributions welcome
Effects of fecal microbiota transplantation and probiotics on the gut microbiome in antibiotic-treated septic patients: A pilot randomized controlled trial
In very sick sepsis patients, FMT helped fix their gut bacteria better than probiotics or no treatment, which might help them survive longer — but the study was too small to prove it for sure, which matches what the claim says.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
Clinical support requires direct evidence. Mechanistic proxy and tangential studies contribute only to the mechanistic score.
- All linked studies are tangential or mechanistic proxies — no direct test of the claim has been found.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Fecal Microbiota Transplantation for Mortality in Critically Ill Sepsis Patients on Antibiotics
Population: Critically ill sepsis patients on antibiotics; Intervention: Fecal microbiota transplantation; Comparator: Standard care, probiotics, or placebo; Outcome: 28-day all-cause mortality; Duration: 28 days; Inclusion: All published randomized and observational studies with adjusted effect estimates.
Double-Blind Randomized Controlled Trial of Fecal Microbiota Transplantation vs. Placebo for 28-Day Mortality in Critically Ill Sepsis Patients on Antibiotics
Population: Critically ill sepsis patients on antibiotics; Intervention: Fecal microbiota transplantation via colonoscopy or nasoenteric tube; Comparator: Placebo (sterile saline or sham procedure); Outcome: 28-day all-cause mortality; Duration: 28 days; Randomization: Stratified by severity score and antibiotic class; Blinding: Double-blind for participants and outcome assessors.
Prospective Cohort Study Comparing 28-Day Mortality in Critically Ill Sepsis Patients Receiving Fecal Microbiota Transplantation vs. Non-Transplant Controls on Antibiotics
Population: Critically ill sepsis patients on antibiotics; Exposure: Receipt of fecal microbiota transplantation; Comparator: Matched controls not receiving transplantation; Outcome: 28-day all-cause mortality; Duration: 28 days; Adjustment: For baseline severity, comorbidities, and antibiotic regimens.
Case-Control Study of Fecal Microbiota Transplantation Exposure in Critically Ill Sepsis Patients Who Died vs. Survived Within 28 Days on Antibiotics
Population: Critically ill sepsis patients on antibiotics; Cases: Died within 28 days; Controls: Survived beyond 28 days; Exposure: History of fecal microbiota transplantation; Adjustment: For age, severity, organ failure, and antibiotic use; Data source: Electronic health records.
Cross-Sectional Analysis of Fecal Microbiota Transplantation Use and 28-Day Mortality in Critically Ill Sepsis Patients on Antibiotics at a Single Time Point
Population: Critically ill sepsis patients on antibiotics; Exposure: Receipt of fecal microbiota transplantation; Outcome: Mortality status at 28 days; Data collection: Single time point after intervention; Adjustment: For baseline demographics and clinical variables.